X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-08-15 | TFFP | Carlson Capital L P | 10% | S - Sale | $0.44 | -216,000 | 10,129,000 | -2% | -$94,433 | |||||
2023-08-15 | TFFP | Weisman Harlan F | Pres, CEO | P - Purchase | $0.25 | +600,000 | 814,615 | +280% | +$150,000 | ||||||
2023-08-15 | TFFP | Rocamboli Stephen | Dir | P - Purchase | $0.25 | +20,000 | 36,000 | +125% | +$5,000 | ||||||
2023-08-15 | TFFP | Roberts Brandi | Dir | P - Purchase | $0.25 | +20,000 | 20,000 | New | +$5,000 | ||||||
2023-08-15 | TFFP | Coleman Kirk Allen | CFO | P - Purchase | $0.25 | +20,000 | 35,675 | +128% | +$5,000 | ||||||
2023-08-15 | TFFP | Mills Robert S | Dir | P - Purchase | $0.25 | +40,000 | 55,980 | +250% | +$10,000 | ||||||
2023-08-15 | TFFP | Mikhak Zamaneh | Chief Medical Officer | P - Purchase | $0.25 | +120,000 | 135,000 | +800% | +$30,000 | ||||||
2023-03-10 | TFFP | Rocamboli Stephen | Dir | P - Purchase | $0.80 | +13,000 | 16,000 | +433% | +$10,433 | ||||||
2023-03-10 | TFFP | Coleman Kirk Allen | CFO | P - Purchase | $0.79 | +12,000 | 15,675 | +327% | +$9,457 | ||||||
2023-03-10 | TFFP | Weisman Harlan F | Pres, CEO | P - Purchase | $0.88 | +150,000 | 214,615 | +232% | +$131,835 | ||||||
2023-03-10 | TFFP | Mikhak Zamaneh | Chief Medical Officer | P - Purchase | $0.82 | +15,000 | 15,000 | New | +$12,300 | ||||||
2022-12-15 | TFFP | Weisman Harlan F | Pres, CEO | P - Purchase | $1.06 | +50,000 | 64,615 | +342% | +$53,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |